A reconciliation of the applicable numerators and denominators of the income statement periods presented, as reflected in the results of continuing operations, is as follows (in thousands, except per share amounts):

 

    Three Months Ended March 31, 2016     Three Months Ended March 31, 2015  
    Loss     Shares     EPS     Loss     Shares     EPS  
Basic                                                
loss per share   $ (1,336 )     17,081     $ (0.08 )   $ (1,380 )     15,892     $ (0.09 )
Dilutives:                                                
Options     -       -       -       -       -       -  
Diluted loss per share   $ (1,336 )     17,081     $ (0.08 )   $ (1,380 )     15,892     $ (0.09 )

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!

Other recent filings from the company include the following:

BML Investment Partners, L.P. just provided an update on share ownership of ProPhase Labs - Jan. 30, 2018
ProPhase Labs's Chief Accounting Officer just declared owning 7,428 shares of ProPhase Labs - Jan. 23, 2018

Auto Refresh

Feedback